Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Phase 1 Study of Fianlimab (Anti–lag-3) in Combination with Cemiplimab (Anti–pd-1) in Patients with Advanced HNSCC.

Journal of Clinical Oncology(2024)

Cited 0|Views2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined